Our pre-clinical services offer robust scientific expertise, numerous in life and end point measurements, phenotyping capabilities, and flexible, customizable study design for compound evaluation for many common models of neurological disorders including Duchenne Muscular Dystrophy (DMD), Rett Syndrome, Friedreich’s Ataxia (FRDA), Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS).
The Jackson Laboratory is a global leader in mammalian genetics and pre-clinical disease modeling, and has been a driving force in supporting drug discovery breakthroughs for over 80 years. Our passion is empowering the development of novel therapeutics in our shared quest to advance human health. Our pre-clinical services offer robust scientific expertise, numerous in life and end point measurements, phenotyping capabilities, and flexible, customizable study design for compound evaluation for many common models of neurological disorders including Duchenne Muscular Dystrophy (DMD), Rett Syndrome, Friedreich’s Ataxia (FRDA), Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS).
Our team has experience evaluating therapies in models of SMA, FA, ALS, Rett Syndrome, and DMD for both commercial and academic researchers for traditional as well as for Neurodegenerative Proof-of-Concept studies.
Get instant access to valuable in-depth manuals and guides:
A Field Guide to Working with Mouse Models of Huntington's Disease
Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management
Price List
Terms and Conditions